BlackRock Institutional Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$362M	Buy	4,373,022 +241,763	+6%	+$20.8M	0.05%	352
2016 Q3	$382M	Buy	4,131,259 +213,394	+5%	+$20.1M	0.06%	321
2016 Q2	$305M	Buy	3,917,865 +108,349	+3%	+$9.21M	0.05%	373
2016 Q1	$314M	Sell	3,809,516 -22,450	-0.6%	-$1.83M	0.05%	358
2015 Q4	$401M	Buy	3,831,966 +17,925	+0.5%	+$1.87M	0.07%	296
2015 Q3	$402M	Buy	3,814,041 +44,477	+1%	+$5.94M	0.07%	285
2015 Q2	$516M	Sell	3,769,564 -10,496	-0.3%	-$1.3M	0.08%	238
2015 Q1	$471M	Buy	3,780,060 +254,895	+7%	+$27M	0.07%	275
2014 Q4	$319M	Buy	3,525,165 +6,906	+0.2%	+$574K	0.05%	366
2014 Q3	$254M	Sell	3,518,259 -3,337	-0.1%	-$219K	0.04%	422
2014 Q2	$219M	Buy	3,521,596 +46,597	+1%	+$2.82M	0.04%	488
2014 Q1	$237M	Buy	3,474,999 +111,165	+3%	+$8.19M	0.04%	437
2013 Q4	$237M	Buy	3,363,834 +164,980	+5%	+$11.2M	0.04%	434
2013 Q3	$231M	Sell	3,198,854 -57,873	-2%	-$3.85M	0.04%	410
2013 Q2	$182M	Buy	+3,256,727	New	+$203M	0.04%	478